Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : CYTO -- Ignore unavailable to you. Want to Upgrade?

To: Jody Ritchie who wrote (7113)	3/30/1998 8:11:00 PM
From: Jerry W	Read Replies (2) \| Respond to of 8116

Jody, You ask if Cytogen will have a release. If you notice the D/M release gives credit to Cytogen. >>Quadramet(R) is manufactured and marketed by the radiopharmaceuticals Division of The DuPont Merck Pharmaceutical Company under the DuPont Pharma name through an exclusive license from CYTOGEN Corporation. CYTOGEN develope the agent under a license from The Dow Chemical Company.<< Cytogens PR people don't have to put out anything, we still have the credit for it. This is a big PLUS. Have a good night. JW